Commission Decision of 03/06/2025 declaring a concentration to be compatible with the common market (Case No COMP/M.11997 - MADISON DEARBORN PARTNERS / THOMA BRAVO / NEXTGEN HEALTHCARE ) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

Id-Deċiżjoni tal-Kummissjoni ta' 03/06/2025 li tiddikjara konċentrazzjoni hija kompatibbli mas-suq komuni (il-Każ Nru COMP/M.11997 - MADISON DEARBORN PARTNERS / THOMA BRAVO / NEXTGEN HEALTHCARE ) skond ir-Regolament tal-Kunsill (KE) Nru 139/2004 (It-test bl-Ingliż biss huwa awtentiku)

Id-Deċiżjoni tal-Kummissjoni ta' 03/06/2025 li tiddikjara konċentrazzjoni hija kompatibbli mas-suq komuni (il-Każ Nru COMP/M.11997 - MADISON DEARBORN PARTNERS / THOMA BRAVO / NEXTGEN HEALTHCARE ) skond ir-Regolament tal-Kunsill (KE) Nru 139/2004 (It-test bl-Ingliż biss huwa awtentiku)

In force